Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Conagra sees 'opportunity' to sell frozen meals to those on weight loss drugs

Published 02/20/2024, 03:59 PM
Updated 02/20/2024, 04:01 PM
© Reuters. FILE PHOTO: Packets of Birds Eye foods, a brand owned by Conagra Brands, are seen in a store in Manhattan, New York, U.S., November 15, 2021. REUTERS/Andrew Kelly/File Photo

By Jessica DiNapoli

NEW YORK (Reuters) - U.S. packaged foods firm Conagra Brands (NYSE:CAG) sees an "opportunity" to sell more frozen meals, meat snacks and popcorn to people using weight-loss drugs like Ozempic, executive Tom McGough said Tuesday at an industry conference.

Investors have worried that U.S. food companies will see sales slide as more people use weight-loss drugs like Ozempic and Wegovy, which curb appetite and lead to feelings of fullness.

Chicago-based Conagra, which makes Healthy Choice frozen meals, Bertolli Italian foods, and Duncan Hines cake mixes, previously said it may have to scale down portions to court consumers using the medications.

"If anything, we see opportunity within our portfolio," McGough said at the Consumer Analyst Group of New York Conference in Boca Raton, Florida.

He said that data from market research firm Numerator shows that consumption of "better-for-you" frozen meals increases 8% among people using the weight-loss drugs.

"Well, why is that? Well, frozen meals are portion-controlled," McGough said. "They provide vegetable nutrition and they're high in protein."

McGough also expects users of the weight-loss medications, called "GLP-1 agonists," to eat more of the company's snacks like Slim Jim beef jerky and Angie's Boomchickapop popcorn.

"That's because meat snacks are high in protein and popcorn is a low-calorie, high-fiber food and among GLP-1 users, consumption of both meat snacks and popcorn increase," he said.

Conagra's competitors, including Kraft Mac and Cheese maker Kraft Heinz (NASDAQ:KHC) and Pringles manufacturer Kellanova, may also face questions from Wall Street analysts on the impact of the drugs on their sales at the conference.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

General Mills (NYSE:GIS) CEO Jeffrey Harmening said at the conference that his company was introducing new products to "meet evolving consumer weight management and nutrition needs."

Annie's Macaroni & Cheese has a new "Super Mac" offering with more protein, for instance, while General Mills is also launching "a protein-forward Progresso soup line and bringing lower sugar offerings to our Betty Crocker cakes, cookies and brownies," Harmening said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.